Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6785160 | 7437204 | I | 6785160-X | 20100602 | 20100618 | EXP | THQ2010A00854 | TAKEDA PHARMACEUTICALS NORTH AMERICA | 88 | YR | M | N | 20100617 | AUSTRALIA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6785160 | 1013918262 | PS | ACTOS | 1 | ORAL | 30 MG, PER ORAL | D | 21073 | |||
| 6785160 | 1013960762 | C | DIAMICRON (GLICLAZIDE) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6785160 | 1013918262 | DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6785160 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6785160 | ABDOMINAL PAIN UPPER |
| 6785160 | DECREASED APPETITE |
| 6785160 | ENZYME ABNORMALITY |
| 6785160 | NAUSEA |
| 6785160 | PANCREATIC CARCINOMA |
| 6785160 | WEIGHT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6785160 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6785160 | 1013918262 | 20080101 | 20091110 | 1 | YR |